• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体外增强心肌的配对刺激作为正性肌力参考标准。

Potentiating paired stimulation of cardiac muscle in vitro as positive inotropic reference standard.

作者信息

Scholtysik G

出版信息

J Pharmacol Methods. 1986 Jul;15(4):367-73. doi: 10.1016/0160-5402(86)90015-x.

DOI:10.1016/0160-5402(86)90015-x
PMID:2425191
Abstract

In rabbit papillary muscles, potentiating paired stimulation was used as a standard positive inotropic intervention. Pairs of depolarizing electrical stimuli were applied, equal in strength and with a coupling interval of the functional refractory period plus 10 msec. After five successive pairs at a basic driving rate of 0.5 Hz, maximum potentiation amounting to a two- to threefold increase in the contraction amplitude was reached. The potentiating paired stimulation was rapid in both onset and reversibility and was reproducible. Potentiating paired stimulation is sparing since internal Ca2+ pools are utilized to increase force. Using potentiating paired stimulation-induced increase in force of contraction as a new reference, the following order of potency of positive inotropic agents was obtained: ouabain greater than DPI 201-106 greater than IBMX greater than APP 201-533. Effects of these drugs on rested-state contractions and frequency-force relationship were also investigated.

摘要

在兔乳头肌中,增强配对刺激被用作标准的正性肌力干预措施。施加成对的去极化电刺激,强度相等,耦合间隔为功能性不应期加10毫秒。以0.5 Hz的基本驱动频率连续施加五对刺激后,收缩幅度达到最大增强,增加了两到三倍。增强配对刺激在起效和可逆性方面都很快,并且可重复。增强配对刺激是节省能量的,因为利用了细胞内钙库来增加力量。以增强配对刺激诱导的收缩力增加作为新的参考,得到了以下正性肌力药物的效价顺序:哇巴因大于DPI 201-106大于异丁基甲基黄嘌呤大于APP 201-533。还研究了这些药物对静息状态收缩和频率-力量关系的影响。

相似文献

1
Potentiating paired stimulation of cardiac muscle in vitro as positive inotropic reference standard.在体外增强心肌的配对刺激作为正性肌力参考标准。
J Pharmacol Methods. 1986 Jul;15(4):367-73. doi: 10.1016/0160-5402(86)90015-x.
2
Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram.大鼠和兔心室肌中环核苷酸磷酸二酯酶同工酶的比较:奥昔非君、米力农和咯利普兰的正性肌力作用及磷酸二酯酶抑制作用
Naunyn Schmiedebergs Arch Pharmacol. 1990 Dec;342(6):698-705. doi: 10.1007/BF00175715.
3
Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.与非衰竭人类心肌标本相比,磷酸二酯酶III抑制剂匹莫苯丹、阿迪苯丹和沙替利酮在衰竭心肌中强心作用减弱的潜在机制。
Naunyn Schmiedebergs Arch Pharmacol. 1991 Jul;344(1):90-100. doi: 10.1007/BF00167387.
4
Interaction of DPI 201-106 with cardiac glycosides.
J Cardiovasc Pharmacol. 1989 Feb;13(2):342-7. doi: 10.1097/00005344-198902000-00026.
5
Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: role of phosphodiesterase inhibition.氨力农、卡巴唑仑和异丁基甲基黄嘌呤的变时性和变力性作用:磷酸二酯酶抑制的作用
Br J Pharmacol. 1989 Sep;98(1):291-301. doi: 10.1111/j.1476-5381.1989.tb16894.x.
6
Screening of positive inotropic agents in isolated cardiac preparations from different sources.在来自不同来源的离体心脏制剂中筛选正性肌力药物。
J Pharmacol Methods. 1989 Mar;21(1):33-44. doi: 10.1016/0160-5402(89)90020-x.
7
Comparison of positive inotropic effects of milrinone, dobutamine and ouabain.米力农、多巴酚丁胺和哇巴因正性肌力作用的比较。
Cardiology. 1994;84(2):99-105. doi: 10.1159/000176527.
8
Positive inotropic and electrophysiological effects of APP 201-533 can be explained by an increase of cardiac cyclic AMP.APP 201 - 533的正性肌力和电生理效应可通过心脏环磷酸腺苷(cAMP)的增加来解释。
J Cardiovasc Pharmacol. 1985 May-Jun;7(3):597-603. doi: 10.1097/00005344-198505000-00028.
9
Concentration-response curves of positive inotropic agents before and after ouabain pretreatment.哇巴因预处理前后正性肌力药物的浓度-效应曲线。
Cardiovasc Res. 1985 May;19(5):288-98. doi: 10.1093/cvr/19.5.288.
10
Cardiac and hemodynamic profile of the new cardiotonic agent, DPI 201-106, in the conscious dog.
Eur J Pharmacol. 1989 Jun 8;165(1):39-49. doi: 10.1016/0014-2999(89)90768-1.